AAPL349.81+5.98 (+1.74%) ▲|ABBV288.72+2.73 (+0.95%) ▲|ABT103.72+1.08 (+1.05%) ▲|ACN246.26+2.86 (+1.18%) ▲|ADBE247.48-2.28 (-0.91%) ▼|AMAT423.89+7.89 (+1.90%) ▲|AMD564.68-13.76 (-2.38%) ▼|AMGN458.62+6.79 (+1.50%) ▲|AMT185.35+1.60 (+0.87%) ▲|AMZN244.78-9.82 (-3.86%) ▼|AVGO344.60-7.21 (-2.05%) ▼|AXP323.85+5.91 (+1.86%) ▲|BA172.66+5.52 (+3.30%) ▲|BAC51.36+0.51 (+0.99%) ▲|BKNG149.26+1.32 (+0.89%) ▲|BLK1,167.49+9.61 (+0.83%) ▲|BMY60.34-0.24 (-0.39%) ▼|BNY149.22+0.63 (+0.42%) ▲|BRK-B543.76+3.42 (+0.63%) ▲|C125.35+1.24 (+1.00%) ▲|CAT646.56-66.82 (-9.37%) ▼|CL92.66+0.97 (+1.06%) ▲|CMCSA22.03+0.46 (+2.11%) ▲|COF208.38+3.50 (+1.71%) ▲|COP149.74+0.68 (+0.46%) ▲|COST992.41+9.68 (+0.98%) ▲|CRM231.39-10.72 (-4.43%) ▼|CSCO108.59-1.70 (-1.54%) ▼|CVS89.61-0.34 (-0.38%) ▼|CVX230.85+1.65 (+0.72%) ▲|DE657.20+16.53 (+2.58%) ▲|DHR234.76+0.69 (+0.29%) ▲|DIS110.84+1.80 (+1.65%) ▲|DUK125.67+2.10 (+1.70%) ▲|EMR169.81+2.10 (+1.25%) ▲|FDX307.07+2.49 (+0.82%) ▲|GD369.16+14.81 (+4.18%) ▲|GE311.05+9.92 (+3.29%) ▲|GEV889.06+11.03 (+1.26%) ▲|GILD161.32+2.12 (+1.33%) ▲|GM85.33+2.85 (+3.45%) ▲|GOOG279.85-42.04 (-13.06%) ▼|GOOGL281.79-43.11 (-13.27%) ▼|GS927.10+1.93 (+0.21%) ▲|HD325.63+8.07 (+2.54%) ▲|HON221.89+2.63 (+1.20%) ▲|IBM255.40+2.18 (+0.86%) ▲|INTC91.33-4.20 (-4.40%) ▼|INTU329.97+1.78 (+0.54%) ▲|ISRG448.52+4.34 (+0.98%) ▲|JNJ274.09+3.05 (+1.13%) ▲|JPM342.57+3.27 (+0.96%) ▲|KO92.46+0.73 (+0.79%) ▲|LIN501.74-6.42 (-1.26%) ▼|LLY1,366.97+78.67 (+6.11%) ▲|LMT647.45+17.70 (+2.81%) ▲|LOW204.60+6.20 (+3.13%) ▲|LRCX254.08+0.26 (+0.10%) ▲|MA635.88+25.57 (+4.19%) ▲|MCD256.22+5.72 (+2.28%) ▲|MDLZ62.35+0.48 (+0.77%) ▲|MDT97.11+2.33 (+2.45%) ▲|META627.07+14.58 (+2.38%) ▲|MMM176.58+3.78 (+2.19%) ▲|MO75.78+2.79 (+3.82%) ▲|MRK146.72+5.79 (+4.11%) ▲|MS190.39+0.26 (+0.14%) ▲|MSFT529.63-1.38 (-0.26%) ▼|MU932.81-50.42 (-5.13%) ▼|NEE81.97+0.95 (+1.17%) ▲|NFLX61.89-0.10 (-0.16%) ▼|NKE38.24+1.09 (+2.92%) ▲|NOW109.74-40.40 (-26.91%) ▼|NVDA212.80-2.59 (-1.20%) ▼|ORCL138.21-6.33 (-4.38%) ▼|PEP133.35+0.72 (+0.54%) ▲|PFE29.62+0.17 (+0.56%) ▲|PG159.75+1.49 (+0.94%) ▲|PLTR194.27-2.54 (-1.29%) ▼|PM207.51+4.87 (+2.40%) ▲|QCOM183.71+0.74 (+0.40%) ▲|RTX200.81+4.97 (+2.54%) ▲|SBUX103.91+0.71 (+0.68%) ▲|SCHW89.22+0.46 (+0.52%) ▲|SO93.12+1.60 (+1.74%) ▲|SPG215.00+3.76 (+1.78%) ▲|T20.95+0.25 (+1.18%) ▲|TMO704.26+0.11 (+0.01%) ▲|TMUS148.11+0.03 (+0.02%) ▲|TSLA405.56+1.34 (+0.33%) ▲|TXN308.24-1.59 (-0.51%) ▼|UBER65.07-0.20 (-0.31%) ▼|UNH404.96-2.14 (-0.53%) ▼|UNP300.57+2.77 (+0.93%) ▲|UPS106.68+1.06 (+1.00%) ▲|USB60.29+0.69 (+1.15%) ▲|V410.49+9.89 (+2.47%) ▲|VZ43.72+0.54 (+1.24%) ▲|WFC84.60+0.93 (+1.11%) ▲|WMT121.19+2.42 (+2.03%) ▲|XOM182.37+0.35 (+0.19%) ▲|AAPL349.81+5.98 (+1.74%) ▲|ABBV288.72+2.73 (+0.95%) ▲|ABT103.72+1.08 (+1.05%) ▲|ACN246.26+2.86 (+1.18%) ▲|ADBE247.48-2.28 (-0.91%) ▼|AMAT423.89+7.89 (+1.90%) ▲|AMD564.68-13.76 (-2.38%) ▼|AMGN458.62+6.79 (+1.50%) ▲|AMT185.35+1.60 (+0.87%) ▲|AMZN244.78-9.82 (-3.86%) ▼|AVGO344.60-7.21 (-2.05%) ▼|AXP323.85+5.91 (+1.86%) ▲|BA172.66+5.52 (+3.30%) ▲|BAC51.36+0.51 (+0.99%) ▲|BKNG149.26+1.32 (+0.89%) ▲|BLK1,167.49+9.61 (+0.83%) ▲|BMY60.34-0.24 (-0.39%) ▼|BNY149.22+0.63 (+0.42%) ▲|BRK-B543.76+3.42 (+0.63%) ▲|C125.35+1.24 (+1.00%) ▲|CAT646.56-66.82 (-9.37%) ▼|CL92.66+0.97 (+1.06%) ▲|CMCSA22.03+0.46 (+2.11%) ▲|COF208.38+3.50 (+1.71%) ▲|COP149.74+0.68 (+0.46%) ▲|COST992.41+9.68 (+0.98%) ▲|CRM231.39-10.72 (-4.43%) ▼|CSCO108.59-1.70 (-1.54%) ▼|CVS89.61-0.34 (-0.38%) ▼|CVX230.85+1.65 (+0.72%) ▲|DE657.20+16.53 (+2.58%) ▲|DHR234.76+0.69 (+0.29%) ▲|DIS110.84+1.80 (+1.65%) ▲|DUK125.67+2.10 (+1.70%) ▲|EMR169.81+2.10 (+1.25%) ▲|FDX307.07+2.49 (+0.82%) ▲|GD369.16+14.81 (+4.18%) ▲|GE311.05+9.92 (+3.29%) ▲|GEV889.06+11.03 (+1.26%) ▲|GILD161.32+2.12 (+1.33%) ▲|GM85.33+2.85 (+3.45%) ▲|GOOG279.85-42.04 (-13.06%) ▼|GOOGL281.79-43.11 (-13.27%) ▼|GS927.10+1.93 (+0.21%) ▲|HD325.63+8.07 (+2.54%) ▲|HON221.89+2.63 (+1.20%) ▲|IBM255.40+2.18 (+0.86%) ▲|INTC91.33-4.20 (-4.40%) ▼|INTU329.97+1.78 (+0.54%) ▲|ISRG448.52+4.34 (+0.98%) ▲|JNJ274.09+3.05 (+1.13%) ▲|JPM342.57+3.27 (+0.96%) ▲|KO92.46+0.73 (+0.79%) ▲|LIN501.74-6.42 (-1.26%) ▼|LLY1,366.97+78.67 (+6.11%) ▲|LMT647.45+17.70 (+2.81%) ▲|LOW204.60+6.20 (+3.13%) ▲|LRCX254.08+0.26 (+0.10%) ▲|MA635.88+25.57 (+4.19%) ▲|MCD256.22+5.72 (+2.28%) ▲|MDLZ62.35+0.48 (+0.77%) ▲|MDT97.11+2.33 (+2.45%) ▲|META627.07+14.58 (+2.38%) ▲|MMM176.58+3.78 (+2.19%) ▲|MO75.78+2.79 (+3.82%) ▲|MRK146.72+5.79 (+4.11%) ▲|MS190.39+0.26 (+0.14%) ▲|MSFT529.63-1.38 (-0.26%) ▼|MU932.81-50.42 (-5.13%) ▼|NEE81.97+0.95 (+1.17%) ▲|NFLX61.89-0.10 (-0.16%) ▼|NKE38.24+1.09 (+2.92%) ▲|NOW109.74-40.40 (-26.91%) ▼|NVDA212.80-2.59 (-1.20%) ▼|ORCL138.21-6.33 (-4.38%) ▼|PEP133.35+0.72 (+0.54%) ▲|PFE29.62+0.17 (+0.56%) ▲|PG159.75+1.49 (+0.94%) ▲|PLTR194.27-2.54 (-1.29%) ▼|PM207.51+4.87 (+2.40%) ▲|QCOM183.71+0.74 (+0.40%) ▲|RTX200.81+4.97 (+2.54%) ▲|SBUX103.91+0.71 (+0.68%) ▲|SCHW89.22+0.46 (+0.52%) ▲|SO93.12+1.60 (+1.74%) ▲|SPG215.00+3.76 (+1.78%) ▲|T20.95+0.25 (+1.18%) ▲|TMO704.26+0.11 (+0.01%) ▲|TMUS148.11+0.03 (+0.02%) ▲|TSLA405.56+1.34 (+0.33%) ▲|TXN308.24-1.59 (-0.51%) ▼|UBER65.07-0.20 (-0.31%) ▼|UNH404.96-2.14 (-0.53%) ▼|UNP300.57+2.77 (+0.93%) ▲|UPS106.68+1.06 (+1.00%) ▲|USB60.29+0.69 (+1.15%) ▲|V410.49+9.89 (+2.47%) ▲|VZ43.72+0.54 (+1.24%) ▲|WFC84.60+0.93 (+1.11%) ▲|WMT121.19+2.42 (+2.03%) ▲|XOM182.37+0.35 (+0.19%) ▲|
19.4 C
New York
Thursday, October 29, 2026

Tag: function

newsFORsourcecompanycontentinformationreleases1market

Wearable EEG Devices Market Size to Grow by USD 695.51 million by 2031, Experiences Growth Owing to Growing Prevalence of Neurological Disorders | The...

NEW YORK, July 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global wearable EEG devices market is...

Wearable EEG Devices Market Size to Grow by USD 695.51 million by 2031, Experiences Growth Owing to Growing Prevalence of Neurological Disorders | The...

NEW YORK, July 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global wearable EEG devices market is...

HotSpot Therapeutics Presents Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025

BOSTON, July 4, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart...

Baleaf and Amazon Celebrate Movement and Community This Independence Day with Limited-Time Activewear Event

NEW YORK, July 4, 2025 /PRNewswire/ -- In celebration of Independence Day, Baleaf, the go-to activewear brand renowned for its inclusive fit and functional style,...

RIPPLECOIN Mining launches smart cloud mining app, making crypto income easier than ever

The new app supports BTC, XRP, DOGE and other currencies, uses AI scheduling system and green energy drive, helping global users to easily realize passive appreciation of crypto assets 
The new app supports BTC, XRP, DOGE and other currencies, uses AI scheduling system and green energy drive, helping global users to easily realize passive appreciation of crypto assets

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Enjoy Exclusive Deals on METZ 4K & QLED TVs at ALZA

PRAGUE, July 4, 2025 /PRNewswire/ -- Premium enjoyment and great value do not have to be a trade-off. From July 4 to 21, 2025, METZ...

Snow Caps THCA Flower – Extra Frosty Exotic Cannabis Strains Now Available for Sale

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe

LEATHERHEAD, England, July 4, 2025 /PRNewswire/ -- MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark,...

High-Potency OTC NMN Supplement from Wonderfeel Launches Amid Surging Demand for Clean NAD+ Support Solutions

Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support. 
Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness 
Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet

Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims. 
Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.

PhenQ Updates 2025 Formula With Strongest OTC Appetite Suppressant Profile and Clinically Studied Craving Support Ingredients

Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription 
Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription

Brain Defender Enters 2025 Cognitive Wellness Spotlight as Demand for Transparent, Non-Stimulant Support Surges

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space. 
As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFunction

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers